Stay Informed on What You’re Vaping With RYAH Smart Technology
October 2nd, 2019
App, Exclusive, News, Top Story
Many consumers believe that vaping is a far safer alternative to smoking, but the recent mysterious deaths of six people and hundreds of cases of respiratory illness potentially linked to electronic cigarettes (e-cigs) or oil -based vaping has certainly raised eyebrows. Officially, an ongoing investigation by the Centers for Disease Control and Prevention hasn’t pegged any specifics to the maladies. However, oil vaping e-cigs seem to be a common denominator.
Without question, the outbreak squarely puts an emphasis on consumer safety. The lack of available information speaks to the value of implementing high-tech in the vape space, as RYAH Medtech has done with its dry-herb dose-measuring vaporizer.
Steer Clear of Bootleg Vape Products
No authorities are certain what exactly is behind the lung illness, although the CDC says it initially sees similarities in several of the deaths regarding vaping THC, the part of marijuana that gets a person “high,” either with or instead of nicotine.
Oil vaporizers work by heating oil-based substances at high temperatures, which turn into liquid aerosols that can be inhaled. Dry-herb vaporizers on the other hand, ‘bake’ plant matter to its boiling point, which creates a water based vapor that can be inhaled. A vapor is different from an aerosol as an aerosol is a suspension of tiny particles of liquid, solid, or both within a gas. For many cigarette smokers, oil vaporizers have been used to help wean them off nicotine.
For the most part, limited information has been available to the public as to the culprit in the pulmonary illnesses. There is certainly a school of thought that illegal cartridges sold on the street are to blame. These products, known by names like Mario Kart and Dank Cart, often use illegal cutting agents, namely vitamin E acetate, which the FDA believes is “prudent” to avoid inhaling.
The CDC has issued a warning against using bootleg vaping products.
Due diligence into the matter shows the regulatory bodies have a substantial challenge in trying to collect all the information to piece the puzzle together to try and make an education decision on the underlying cause of the epidemic.
“The FDA, CDC and local authorities have their plates full when it comes to analyzing legal products for potential contaminants like pesticides, heavy metals, and diluents, not to mention illicit products,” commented Gregory Wagner, CEO of RYAH, in a phone call on the matter with CFN Media Group. “Public safety is our top priority and has been a driving force in our commitment to develop and commercialize our smart vaporizer and proprietary cartridges,” he added. “RYAH dry-herb cartridges all require unique QR codes that are created using RYAH proprietary software. The QR codes cannot be produced without an authenticated certificate of analysis (COA). Each COA is reviewed by RYAH itself. Without the QR code, RYAH devices simply will not turn on. Hence, illicit products cannot be used in RYAH devices.”
Big Data and Next Generation Vaping
Focused on the plant-based medical market, RYAH is a first mover with its novel vaporizer featuring innovative technologies with commercial-grade materials. Notably, the RYAH vaporizer has a diffused mouthpiece and even heat distribution, while RYAH cartridges prevent material from directly touching the heating chamber, keeping the vaporizer extraordinarily clean.
The real differentiator is the smart technology that gathers information about exactly what the user is inhaling. Airflow sensors record precisely how much is inhaled. Each cartridge, whether dry-herb or oil, has a QR code with all the information on the product being used.
The RYAH application completes the system, collecting all the data to give the user – and any authorized party – access to a detailed view of usage. The app, available for both iOS and Android, gives the user complete control, all the way down to heating temperatures and limitations on how much can be inhaled.
In July, RYAH’s HIPAA-compliant products began hitting the shelves at medical dispensaries in the U.S. Shortly after, RYAH partnered with SOS Cannabis to work with Canadian patients to seek reimbursement from different government agencies for the medical costs associated with purchasing the RYAH’s vaporizer and cartridges. RYAH’s cartridges have a Class I license from Health Canada.
“Our goal is to work with every grower, doctor and researcher to set new standards for vaporizer products for the purpose of protecting consumers by building a robust library of data,” said Wagner. “We need to ensure that patients are educated and can get their products affordably, so they don’t risk their health by turning to the black market. That’s what we’re making happen at RYAH,” he concluded.
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.